z-logo
open-access-imgOpen Access
Use of continuous subcutaneous insulin infusion by a portable insulin pump during pregnancy in women with type 1 diabetes mellitus
Author(s) -
Svetlana Zorić,
Dragan Micić,
Aleksandra Kendereški,
Mirjana Šumarac-Dumanović,
Goran Cvijović,
Danica Pejković,
Miloš Cvetković,
Aleksandar Ljubić,
Jelena Stamenković
Publication year - 2006
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp0607648z
Subject(s) - medicine , insulin pump , pregnancy , insulin , diabetes mellitus , type 1 diabetes , infusion pump , endocrinology , obstetrics , anesthesia , biology , genetics
Diabetes mellitus is associated with an increased risk for neonatal morbidity and mortality. One of the most important goals in treating pregnancies complicated with diabetes is keeping glucose level within the normal range, especially in the first trimester. A portable insulin pump for continuous subcutaneous insulin infusion (CSII) represents the best form of therapy for patients with type 1 diabetes mellitus during pregnancy. The aim of our study was to evaluate the effects of therapy with a portable insulin pump for continuous subcutaneous insulin infusion during the first trimester of pregnancy on the quality of glycoregulation and pregnancy outcome in women with type 1 diabetes mellitus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom